PharmaCyte Biotech (PMCB) Stock: Buy, Sell, or Hold?
PMCB - PharmaCyte Biotech, Inc. Common Stock
$0.35
0.00 (0.78%)
▲
5d:
-2.07%
30d:
-18.32%
90d:
-41.68%
WAIT
LOW Confidence
Analysis Updated: Oct 22, 2026 12:00 AM ET
Earnings: Sep 21, 2026
0d
Get Alerted When PMCB Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: PMCB shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: PMCB shows conflicting indicators. Wait for confirmation before entering.
In-depth Analysis How we analyze
Valuation Analysis: PMCB is currently trading at $0.35, which is considered oversold relative to its 30-day fair value range of $0.36 to $0.44.
Technical Outlook: Technically, PMCB is in a strong downtrend. The price is currently testing key support at $0.34. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: PMCB scores 68/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, PMCB is in a strong downtrend. The price is currently testing key support at $0.34. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: PMCB scores 68/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$0.36 -
$0.44
Company Quality Score
49/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
94.1%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (68/100)
- BULLISH: High volume confirmation
- WARNING: Composite score 49/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$0.36 -
$0.44
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$0.34
Resistance Level
$0.41
Current Trend
Strong Downtrend
Technical data as of
Oct 22, 2026
Fundamental Context
Forward P/E (Next Year Est.)
7.02
Share & Embed Analysis
Last updated: October 23, 2026 5:14 AM ET
Data refreshes hourly during market hours. Next update: 6:14 AM
Data refreshes hourly during market hours. Next update: 6:14 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is PMCB showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
VRTX
Vertex Pharmaceuticals I… |
STRONG BUY
32 analysts |
$571 | 49 HOLD |
|
ALNY
Alnylam Pharmaceuticals … |
STRONG BUY
30 analysts |
$369 | 50 HOLD |
|
ONC
BeiGene, Ltd. |
STRONG BUY
27 analysts |
$436 | 39 SELL |
|
ASND
Ascendis Pharma AS |
STRONG BUY
21 analysts |
$307 | 51 HOLD |
|
RYTM
Rhythm Pharmaceuticals I… |
STRONG BUY
18 analysts |
$144 | 70 BUY |
